Clinical trial
Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA…
NCT00296855 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00296855 |
|---|---|
| Title | Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease |
| Official title | Intra-individual Open-label Multicenter Comparison Study of Magnetic Resonance Angiography (MRA) With the Blood Pool Contrast Agent Vasovist® and a Conventional Extracellular Contrast Agent With Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients With Peripheral Artery Disease |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Peripheral Vascular Diseases |
| Intervention type | Drug |
| Interventions | Vasovist (BAY86-5283, MS-325) |
| Enrollment | 261 |
| Start date | Feb 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Feb 27, 2006 |
| Last update posted | Apr 23, 2010 |
| Countries | Argentina, Austria, Brazil, Germany, Mexico, Switzerland |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: